SCHEMBL5418399

SCHEMBL5418399

Cc1ccc(CCN(CCC(=O)O)C(=O)c2ccccc2-c2ccccc2C(=O)NCc2ccccc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
HPGD P15428 4/20 0.49
KDM4E B2RXH2 2/20 0.49
CHRNB2 P17787 1/20 0.49
CHRNB4 P30926 1/20 0.49
CHRNA3 P32297 1/20 0.49
CHRNA4 P43681 1/20 0.49
HDAC1 Q13547 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.46
KMT2A Q03164 3/20 0.45
MEN1 O00255 1/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 1/20 0.45
TP53 P04637 1/20 0.44
GLA P06280 1/20 0.44
APEX1 P27695 1/20 0.43
PPARG P37231 1/20 0.43
LMNA P02545 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5399793 1.00 ALDH1A1 (0.57) ALDH1A1HPGDKDM4ECHRNB2CHRNB4
SCHEMBL5402458 0.99 ALDH1A1 (0.55) ALDH1A1HPGDKDM4ECHRNB2CHRNB4
SCHEMBL5399261 0.95 ALDH1A1 (0.56) ALDH1A1HPGDKDM4ECHRNB2CHRNB4
SCHEMBL5402442 0.94 ALDH1A1 (0.50) ALDH1A1HPGDKDM4ECHRNB2CHRNB4
SCHEMBL5399508 0.94 ALDH1A1 (0.50) ALDH1A1HPGDKDM4ECHRNB2CHRNB4
SCHEMBL5409780 0.93 CHRNB2 (0.56) ALDH1A1HPGDCHRNB2CHRNB4CHRNA3
SCHEMBL5409176 0.93 MAPK1 (0.50) ALDH1A1HPGDKDM4ECHRNB2CHRNB4
SCHEMBL5413978 0.93 ALDH1A1 (0.50) ALDH1A1HPGDKDM4ECHRNB2CHRNB4
SCHEMBL5416741 0.92 TP53 (0.49) ALDH1A1HPGDKDM4EHDAC1HDAC6
SCHEMBL5408973 0.92 NR1H4 (0.52) ALDH1A1HPGDKDM4ECHRNB2CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285680-B2 β-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-10-23 US disclosed
US-20050256160-A1 Beta-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2005-11-17 US disclosed
EP-1533294-A1 BETA-ALANINE DERIVATIVE AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256160-A1 Beta-alanine derivatives and the use thereof TGFB1, PML, APOB ALDH1A1 1256/4885HPGD 1078/4885KDM4E 4680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.